These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9099325)

  • 21. Single-dose ciprofloxacin versus 3 days of norfloxacin in uncomplicated urinary tract infections in women.
    Auquer F; Cordón F; Gorina E; Caballero JC; Adalid C; Batlle J;
    Clin Microbiol Infect; 2002 Jan; 8(1):50-4. PubMed ID: 11906502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative evaluation of efficacy and safety of ciprofloxacin and norfloxacin ophthalmic solutions.
    Adenis JP; Brasseur G; Demailly P; Malet F; Verin P; Saint-Blancat P; Retout A; Ollé P; Colin J
    Eur J Ophthalmol; 1996; 6(3):287-92. PubMed ID: 8908436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nalidixic acid is still the drug of choice for shigellosis in Pakistan.
    Mahmood A
    J Pak Med Assoc; 2001 Feb; 51(2):101. PubMed ID: 11321869
    [No Abstract]   [Full Text] [Related]  

  • 24. Antimicrobial therapy for shigellosis.
    Salam MA; Bennish ML
    Rev Infect Dis; 1991; 13 Suppl 4():S332-41. PubMed ID: 2047659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of lomefloxacin as compared to norfloxacin in the treatment of uncomplicated urinary tract infections in adults.
    Iravani A
    Am J Med; 1992 Apr; 92(4A):75S-81S. PubMed ID: 1316075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term magnetic resonance survey of cartilage damage in leukemic children treated with fluoroquinolones.
    Aricò M; Bossi G; Caselli D; Cosi G; Villa A; Beluffi G; Genovese E
    Pediatr Infect Dis J; 1995 Aug; 14(8):713-4. PubMed ID: 8532433
    [No Abstract]   [Full Text] [Related]  

  • 27. Antimicrobial susceptibility of Shigella flexneri and S. dysenteriae isolated from stool specimens of patients with bloody diarrhoea in Mwanza, Tanzania.
    Temu MM; Kaatano GM; Miyaye ND; Buhalata SN; Shushu ML; Kishamawe C; Changalucha JM
    Tanzan Health Res Bull; 2007 Sep; 9(3):186-9. PubMed ID: 18087897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shigellosis.
    Niyogi SK
    J Microbiol; 2005 Apr; 43(2):133-43. PubMed ID: 15880088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. International note. Antibiotics in the management of shigellosis.
    Can Commun Dis Rep; 2004 Dec; 30(23):202-3. PubMed ID: 15603533
    [No Abstract]   [Full Text] [Related]  

  • 30. The changing epidemiology of bacillary dysentery and characteristics of antimicrobial resistance of Shigella isolated in China from 2004-2014.
    Chang Z; Zhang J; Ran L; Sun J; Liu F; Luo L; Zeng L; Wang L; Li Z; Yu H; Liao Q
    BMC Infect Dis; 2016 Nov; 16(1):685. PubMed ID: 27863468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increasing incidence of resistance to nalidixic acid in shigellas from humans in England and Wales: implications for therapy.
    Cheasty T; Day M; Threlfall EJ
    Clin Microbiol Infect; 2004 Nov; 10(11):1033-5. PubMed ID: 15522014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lomefloxacin versus norfloxacin in the treatment of uncomplicated urinary tract infections: three-day versus seven-day treatment. The South Swedish Lolex Study Group.
    Neringer R; Forsgren A; Hansson C; Ode B
    Scand J Infect Dis; 1992; 24(6):773-80. PubMed ID: 1337623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activities of aqueous extracts of Mallotus oppositifolium on Shigella dysenteriae A1-induced diarrhoea in rats.
    Kamgang R; Vidal Pouokam Kamgne E; Fonkoua MC; Penlap N Beng V; Biwolé Sida M
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):89-94. PubMed ID: 16445705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term pefloxacin therapy in Madagascan children with shigellosis due to multiresistant organisms.
    Guyon P; Cassel-Beraud AM; Rakotonirina G; Gendrel D
    Clin Infect Dis; 1994 Dec; 19(6):1172-3. PubMed ID: 7888566
    [No Abstract]   [Full Text] [Related]  

  • 35. Multicenter, randomized, double blind clinical trial of short course versus standard course oral ciprofloxacin for Shigella dysenteriae type 1 dysentery in children.
    Zimbabwe, Bangladesh, South Africa (Zimbasa) Dysentery Study Group
    Pediatr Infect Dis J; 2002 Dec; 21(12):1136-41. PubMed ID: 12488664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperimmune bovine colostrum in the treatment of shigellosis in children: a double-blind, randomized, controlled trial.
    Ashraf H; Mahalanabis D; Mitra AK; Tzipori S; Fuchs GJ
    Acta Paediatr; 2001 Dec; 90(12):1373-8. PubMed ID: 11853331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Norfloxacin-induced hallucination--an unusual CNS toxicity of 4-fluoroquinolones.
    Kundu AK
    J Assoc Physicians India; 2000 Sep; 48(9):944. PubMed ID: 11198813
    [No Abstract]   [Full Text] [Related]  

  • 38. Shigella isolation in Vellore, south India (1997-2001).
    Jesudason MV
    Indian J Med Res; 2002 Jan; 115():11-3. PubMed ID: 12424931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacokinetics and clinical studies of norfloxacin in the pediatric field].
    Motohiro T; Yoshinaga Y; Tsumura N; Oki S; Sasaki H; Aramaki M; Oda K; Kawakami A; Koga T; Shimada Y
    Jpn J Antibiot; 1990 May; 43(5):901-17. PubMed ID: 2202843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Empiric treatment of acute diarrheal disease with norfloxacin. A randomized, placebo-controlled study. Swedish Study Group.
    Wiström J; Jertborn M; Ekwall E; Norlin K; Söderquist B; Strömberg A; Lundholm R; Hogevik H; Lagergren L; Englund G
    Ann Intern Med; 1992 Aug; 117(3):202-8. PubMed ID: 1616214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.